NEW YORK, Oct. 11, 2012 \/PRNewswire\/ --Reportlinker.com announces that a new market research report is available in its catalogue: <\/p>\n
http:\/\/www.reportlinker.com\/p0234688\/Medical-Imaging-Markets-Molecular-Imaging.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Medical_Imaging<\/a> <\/p>\n Molecular imaging techniques include nuclear medicine imaging positron emission tomography (PET) and single photon emission computed tomography (SPECT) and combination PET\/CT and SPECT\/CT techniques as well as ultrasound, magnetic resonance imaging (MRI) and computed tomography (CT) imaging that are used with molecular imaging agents. <\/p>\n Molecular imaging has evolved into a pillar of molecular medicine. It combines functional imaging with structural imaging so that specific in-vivo molecular processes can be identified and spatially pinpointed, often with the use of imaging contrast agents that bind to specific biological proteins. Molecular imaging is undertaking diagnostic and treatment roles as it enables physicians to pinpoint the locations of disease and track the progress of therapies. The same contrast agents used to highlight disease sites may even be able to carry drugs that can be selectively unleashed precisely where they are needed. <\/p>\n Medical Imaging Markets: Molecular Imaging offers complete market coverage of world markets for molecular imaging products for the following technologies: <\/p>\n For each of these modalities, the report provides current market size based on revenues to manufacturers of imaging systems used for molecular procedures, as well as forecasts of future revenues. <\/p>\n Interest in and use of the technology has exploded in recent years, thanks to advances in cell biology, biochemical agents, and computer analysis, and serious market watchers in medical imaging industries, as well as those serving or investing in medical imaging companies, will want to keep abreast of this new market. As part of its comprehensive coverage, <\/p>\n includes: <\/p>\n Kalorama looks at the technologies currently used in molecular imaging but also examines novel research areas, such as: <\/p>\n Market forecasts are based on an examination of current market conditions and on investigations into the development of new products by key companies. The market data provide multiple year forecasts for different product segments covered in the report. The information presented in this report is the result of data gathered from company product literature and other corporate brochures and documents, as well as information found in the scientific and trade press. In addition, interviews were conducted with company executives, clinicians and researchers. <\/p>\n<\/p>\n Go here to read the rest: <\/p>\n Medical Imaging Markets: Molecular Imaging<\/a><\/p>\n","protected":false},"excerpt":{"rendered":" NEW YORK, Oct. 11, 2012 \/PRNewswire\/ --Reportlinker.com announces that a new market research report is available in its catalogue: http:\/\/www.reportlinker.com\/p0234688\/Medical-Imaging-Markets-Molecular-Imaging.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Medical_Imaging<\/a> Molecular imaging techniques include nuclear medicine imaging positron emission tomography (PET) and single photon emission computed tomography (SPECT) and combination PET\/CT and SPECT\/CT techniques as well as ultrasound, magnetic resonance imaging (MRI) and computed tomography (CT) imaging that are used with molecular imaging agents Continue reading